title: Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571.
authors.affiliation: The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: Pia
authors.initials: P
authors.lastname: Raanani
authors.forename: John M
authors.initials: JM
authors.lastname: Goldman
authors.forename: Isaac
authors.initials: I
authors.lastname: Ben-Bassat
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate